Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
PHE has awarded an interim contract to Life Technologies Ltd (Thermo Fisher Scientific) for the provision of purchase of TaqMan SARS-CoV-2 Mutation panel to facilitate in the identification and discrimination of the SARS CcV 2 variants VOC20DEC01, VOC20DEC02 and VOC21JAN02 .
The roll out of these panels will help to increase the national coverage of the identification of SARS-CoV-2 across the country.
It is a PHEwide 6 month contract with an option to extend for a further 6 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| LIFE TECHNOLOGIES LIMITED | SC083107 | £150,000 | - |
Government spending data: This supplier has received £1,064,370,902 in 3,313 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Police Scotland, Manchester University NHS Foundation Trust, DEFRA and 8 more public bodies (2016-07-25 to 2026-03-30). View full payment history →